Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro [PDF]
Molecules, 2020 Alzheimer’s disease (AD) and Parkinson’s disease (PD), including dementia with Lewy bodies (DLB), account for the majority of dementia cases worldwide.
Janett Köppen +14 more
doaj +4 more sources
Early Divergence in Misfolding Pathways of Amyloid‐Beta Peptides [PDF]
ChemPhysChem, 2021 Nasrollah Rezaei-Ghaleh +2 more
exaly +2 more sources
Amyloid-Beta Peptides Trigger Premature Functional and Gene Expression Alterations in Human-Induced Neurons [PDF]
Biomedicines, 2023 Philippe Amouyel +2 more
exaly +2 more sources
Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease [PDF]
Cells, 2020 Timofey S Rozhdestvensky +2 more
exaly +2 more sources
Overpressure Exposure From .50-Caliber Rifle Training Is Associated With Increased Amyloid Beta Peptides in Serum [PDF]
Frontiers in Neurology, 2020 Bharani Thangavelu +2 more
exaly +2 more sources
On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications [PDF]
Frontiers in Immunology, 2020 Lilia Kucheryavykh +2 more
exaly +2 more sources
Amyloid Beta Peptides Block New Synapse Assembly by Nogo Receptor-Mediated Inhibition of T-Type Calcium Channels [PDF]
Neuron, 2017 Zachary Wills +2 more
exaly +2 more sources
DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet? [PDF]
PLoS ONE, 2011 Numerous reports have documented the beneficial effects of dietary docosahexaenoic acid (DHA) on beta-amyloid production and Alzheimer's disease (AD).
Zareen Amtul +5 more
doaj +1 more source
MethodsX, 2022 Alzheimer´s disease is characterized by hyperphosphorylated tau neurofibrillary tangles and beta-amyloid plaques. Both molecules can be easily measured in human fluids or tissue extracts by immunoassays.
Dhwani S. Korde, Christian Humpel
doaj +1 more source
Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease. [PDF]
PLoS ONE, 2014 Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention as a potential therapy for Alzheimer's disease due to its ability to degrade the peptide amyloid beta.
Carl I Webster +11 more
doaj +1 more source